General Information
Otsuka PTSD 331-201-00071
A Phase 3, Multicenter, Randomized, Double-blind Trial of Brexpiprazole as Combination Therapy with Sertraline in the Treatmentof Adults with Post-Traumatic Stress Disorder
| Protocol | 331-201-00071 |
|---|---|
| Identifier | Project Code 7003928 |
| UID | e97bf09d-40f3-499b-b0d0-be6b7e35b241 |
| Status | Done - Archived |
| Phase | 3 |
| Category | / Adult |
| Launch Year | 2020 |
| NCT Number | - |
| Created | 2019-11-19 09:36 |
| Last Updated | 2022-05-31 14:31 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2021-09-08 | No |
| Enrollment Open | 2020-07-02 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2020-06-17 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2022-05-18 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Volk, Stephen | SVolk | No |
| Recruiter | Farand, Mashgan | MFarand | No |
| Coordinator | Lara, Edward | ELara | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Otsuka Pharmaceuticals |
|---|---|
| Division | Otsuka Pharmaceuticals |
| Team | Otsuka Pharmaceuticals |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Syneos Health |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
